Publication for Fasn and Tkt

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
mmu	Fasn	fatty acid synthase	14104			[link]
mmu	Tkt	transketolase	21881

Pubmed ID	Priority	Text
28241431	0.98	transketolase), and de novo lipogenic (genes encoding fatty acid synthase and acetyl CoA carboxylase) pathways (Figure 4).
30405056	0.98	Tkt, Acc1, and Fasn) were increased by ChREBP overexpression.
19727392	0.97	FAS, transketolase and malic enzyme 1 (ME1), displayed the most prominent suppression in response to VHFD feeding.
	0.97	FAS and transketolase) and detoxification processes, as well as cytoskeleton structural components.
20953342	0.93	fatty acid synthase (FAS, +270%, P < .001), and the stearoyl-Coenzyme A desaturase (Scd1, +455%, P < .001) or was involved in the pentose phosphate pathway such as the transketolase (Tkt, +74%, P < .001) and phosphogluconate dehydrogenase (Pgd, +117%, P < .001).
	0.93	Fasn (+240%, in 30 mg/kg RSG group and +674%, in db/+ group, P < .001) or the pentose phosphate pathway gene Tkt (+86%, in 30 mg/kg RSG group and +409% in db/+ group, P < .001) (Figure 4(a)).
20415584	0.91	Fasn, G6pdh, and Me:but also include Pyruvate kinase, Malate dehydrogenase, Transketolase, Fruc-tokinase, Glycerol phosphate dehydrogenase, and Microsomal triglyceride transfer protein, genes not responsive to SREBP-1c.